Tailored Helicobacter pylori eradication therapy in obese patients undergoing bariatric surgery.
Oscar Laudanno, Gabriel Ahumarán, Pablo Gollo...
https://pubmed.ncbi.nlm.nih.gov/33244981Actively Recruiting
Age: 18Years +
All Genders
ID06579365
Argentinean Registry on the Management of Helicobacter Pylori Infection
Led by University of Buenos Aires · Updated on 2024-08-30
5000
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Helicobacter pylori (H pylori) infection is a major cause of chronic gastritis and peptic ulcer disease, and it increases the risk of gastric cancer and certain lymphomas. About half of the Argentinean population is infected, but the best way to manage this infection is unclear. Treatments are often given without knowing the bacteria's resistance to antibiotics. This research aims to collect detailed information from Argentinean gastroenterologists about how they treat H pylori in routine practice to help identify the most effective therapies and improve antibiotic use. The study is a national, multicenter, prospective, non-interventional registry started in May 2021. It records data from adult patients treated for H pylori by gastroenterologists in Argentina. Researchers gather information on diagnosis, treatment types and doses, length of treatment, adherence, use of probiotics, side effects, and treatment outcomes. This registry collects real-world data without changing the care patients receive. Participants provide data through their doctors who routinely test for H pylori cure after treatment. The study measures include the effectiveness of eradication treatments at least 4 to 6 weeks after therapy, diagnostic methods, frequency of side effects, treatment effectiveness related to body mass index, and patient compliance during a 90-day follow-up. The study is ongoing with ethical approval and aims to improve understanding of H pylori management in Argentina.
CONDITIONS
Brief Title
Argentinean Registry on the Management of Helicobacter Pylori Infection
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Adult patients infected with Helicobacter pylori
You will not qualify if you...
- Pregnant or breastfeeding women
- Subjects currently taking any antibiotics
- Use of antibiotics or bismuth in the previous 4 weeks or proton pump inhibitors in the previous 2 weeks
- Unable or refuse to give consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Monitoring
Duration - Up to 90 days
Participants who undergo routine care for Helicobacter pylori infection are observed to collect data on diagnostic methods, treatments, and outcomes.
Visits occur as part of routine clinical practice; frequency depends on participant care needs
Trial Site Locations
Total: 1 location
1
Instituto de Investigaciones Medicas Alfredo Lanari. Universidad de Buenos Aires
Ciudad de Buenos Aires, Argentina, 1427
Actively Recruiting
Loading map...
Research Team
O
Oscar M Laudanno, MD
G
Gabriel E Ahumarán, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here